Join Sonic Incytes at ACG 2021

You’re invited! Join Sonic Incytes at ACG 2021.

VelacurTM, the first handheld 3D liver health assessment solution, is coming to ACG 2021.

If you care for patients with chronic liver disease or are interested in building your practice, we invite you to connect with us at the ACG 2021 Annual Scientific Meeting in Las Vegas.

Join us in person on October 24 or 25 for a private VelacurTM demo or KOL presentation to learn more.

Register below. Limited spots available.

 

VelacurTM Demos & Info Sessions

Discover how fast, accurate and easy VelacurTM is to assess liver health. Book a private, in-person session with our team on October 24 or 25. Light refreshments included.

Register 

 

Reception & Keynote: “Owning NAFLD: A Win-Win for Patients & Providers” with Dr. Reed Hogan

October 24, 7-8:30PM PT

Understand why owning NAFLD makes sense for your practice, and the steps you can take to make this happen from GI Dr. Reed B. Hogan II. Cocktails and appetizers included.

Register for this free, in-person event.

 

Roundtable Breakfast: “Leveraging Trends to Grow Your GI Practice” with Praveen Suthrum

October 25, 7-8AM PT

Learn how you can leverage emerging trends to grow your GI practice with entrepreneur and health care futurist Praveen Suthrum. Breakfast included.

Register for this free, in-person event.

 

Roundtable Lunch: “Next-Gen NITS for Managing NAFLD/NASH” with Dr. Robert Gish

October 25, 1-2PM PT

Join Dr. Robert Gish to discover breakthrough, non-invasive tests to detect liver disease and best practices to integrate them into your practice. Lunch included.

Register for this free, in-person event.

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our e-newsletter.

Julia PinterMarketing Director

Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.